Flu antivirals prescribable at NHS expense

GPs can now prescribe antiviral medicines for the prophylaxis and treatment of influenza at NHS expense, in accordance with NICE guidance and the NHS Selected List Scheme (SLS).

Vaccines for the 2012/2013 season contain A/California/7/2009 as the H1N1-like virus strain, with A/Victoria/361/2011 as the H3N2-like component and B/Wisconsin/1/2010 as the influenza B component.
Vaccines for the 2012/2013 season contain A/California/7/2009 as the H1N1-like virus strain, with A/Victoria/361/2011 as the H3N2-like component and B/Wisconsin/1/2010 as the influenza B component.

The Department of Health decision was based on Health Protection Agency surveillance data showing an increase in flu activity.

Further information regarding at-risk groups and patients who are eligible for treatment at NHS expense with either Tamiflu (oseltamivir) or Relenza (zanamivir) can be found in Part XVIIIB of the Drug Tarrif.

GPs will be required to endorse prescriptions for the two influenza drugs with ‘SLS’.

Viroflu now available

In addition, the flu vaccine Viroflu (Janssen-Cilag) is now available for the current flu season.

View Viroflu drug record

View Tamiflu drug record

View Relenza drug record

Further information: Green Book – Chapter 19: Influenza

NICE guidance on the use of antiviral medicines for treatment of influenza.

NICE guidance on the use of antiviral medicines for prophylaxis of influenza.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

New antibiotic prescribing guidance issued for pneumonia

New antibiotic prescribing guidance issued for pneumonia

NICE has published antimicrobial prescribing guidelines...

MIMS summary of NICE COPD guidance updated

MIMS summary of NICE COPD guidance updated

Prescribers can now consult the quick-reference MIMS...

Soft-mist inhaler now available as reusable device

Soft-mist inhaler now available as reusable device

Respimat is now available as a reusable inhaler that...

NICE recommends 'innovative' treatment for type I diabetes

NICE recommends 'innovative' treatment for type I diabetes

Dapagliflozin (Forxiga) has been approved for routine...